Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- Check6 days agoChange DetectedThe homepage blurb now shows 590,354 studies with locations in all 50 states and in 226 countries and territories. This replaces the previous count of 589,453 studies.SummaryDifference0.9%

- Check14 days agoChange DetectedNew homepage sections provide direct links for How to Search for Clinical Studies, Common Questions, How to Join a Study, and For Patients and Caregivers, improving user guidance. The site-wide stat is updated to 589,453 studies with locations in all 50 states and 226 countries and territories, replacing the previous worldwide phrasing and updating the revision version to v3.6.0.SummaryDifference0.9%

- Check21 days agoChange DetectedThe footer revision label was updated from v3.5.4 to v3.5.5, indicating a new site release.SummaryDifference0.1%

- Check42 days agoChange DetectedThe footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small software update to the page without changing visible content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe footer now displays Revision: v3.5.3, signaling a new software release for the ClinicalTrials.gov page. This update is a release-level change and does not change the visible content or functionality of the page.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0. This reflects a minor version update on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.